REG - Futura Medical PLC - Grant of Options <Origin Href="QuoteRef">FUM.L</Origin>

Futura MedicalAnnouncement

29/10/2014 12:03

RNS Number : 7465R
Futura Medical PLC
16 September 2014
For immediate release
16 September 2014
Futura Medical plc
("Futura" or "the Company")
Grant of Options
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that on 12 September 2014 it granted options over a total of 580,000 ordinary shares of 0.2p each in the Company to Directors as detailed below.
Director
Number
of options
granted
Exercise
price
Exercise period
Total number
of options
held following
notification
Total number
of ordinary
shares held
J H Barder
250,000
51.75p
1 Oct 2016 - 30 Sep 2021
1,250,000
1,008,830
D B Davies
200,000
51.75p
1 Oct 2016 - 30 Sep 2021
 980,000
 751,306
D A Martin
130,000
51.75p
1 Oct 2016 - 30 Sep 2021
 719,279
 280,000
All options were granted under the Futura Medical plc Unapproved Share Option Scheme with the exception of 103,961 options granted to D A Martin which were granted under the Futura Medical plc Enterprise Management Incentive Scheme.
The main vesting condition of the options is that the Directors remain employed with the Company as at the date of exercise.
For any further information please contact:
Futura Medical plc
James Barder, Chief Executive
Tel: +44 (0)1483 685 670
mail to:james.barder@futuramedical.com
www.futuramedical.com
Nominated Adviser:
N+1 Singer
Aubrey Powell / Thomas Smale
Tel:+44 (0)20 7496 3000


For media enquiries please contact:
Buchanan
Mark Court / Fiona Henson / Sophie Cowles
Tel: +44 (0)20 7466 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com 

This information is provided by RNS
The company news service from the London Stock Exchange
  END
RDSLFFILAIIELIS